Companies: 10,795·Total market cap: $144.5T
Scientific and Medical Equipment House Company

Scientific and Medical Equipment House Company

4014.SRSAUHealthcare● Active
$31.50
$-0.10(-0.32%)
Market Cap$945000000
P/E Ratio
52W High$41
52W Low$26
Overview

Scientific and Medical Equipment House Company (4014.SR) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

4014.SR · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$20.5M -76.8% vs prior year
FY · as of Dec 31, 2025 · Reported in SAR
Cash & Cash Equiv. (CCE)
$20.5M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-76.8%
vs prior fiscal year
Latest Quarter
$40.3M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in SAR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$20.5MCash on Hand
Total Debt$191.5MTotal Debt
Net Cash / Net Debt−$171.0MNet Debt Position
Cash vs Debt Ratio
Cash 10%Debt 90%

Scientific and Medical Equipment House Company carries a net debt position of $171.0M. Total debt ($191.5M) exceeds cash on hand ($20.5M). Scientific and Medical Equipment House Company cash vs debt ratio: 10% cash / 90% debt.

Net Cash = Cash & ST Investments − Total Debt$20.5M$191.5M = −$171.0M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
4014.SR annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$20.5M-76.8%
Dec 31, 2024$88.1M+419.6%
Dec 31, 2023$16.9M-68.9%
Dec 31, 2022$54.6M+20.4%
Dec 31, 2021$45.3M-90.5%
4014.SR cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.5%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.5%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Scientific and Medical Equipment House Company
Scientific and Medical Equipment House CompanyYOU
4014.SR
$20.5M2.2%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Scientific and Medical Equipment House Company (4014.SR) cash on hand as of December 31, 2025 is $20.5M, comprising $20.5M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Scientific and Medical Equipment House Company cash and short-term investments on the balance sheet (10-K filing). Also referred to as Scientific and Medical Equipment House Company cash reserves or cash position.

Scientific and Medical Equipment House Company annual cash on hand history shows decreased -76.8% in 2025: decreased -76.8% in 2025. Scientific and Medical Equipment House Company cash reserves in 2025 reflect the company's capital allocation strategy.

Scientific and Medical Equipment House Company carries total debt of $191.5M against cash of $20.5M, resulting in a net debt position of -$171.0M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

4014.SR cash on hand · 5 questions

As of December 31, 2025, Scientific and Medical Equipment House Company (4014.SR) has $20,472,235 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $20,472,235 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $40,276,536. Data sourced from the annual 10-K filing via FMP.

4014.SR cash on hand4014.SR cash reserves4014.SR cash 2025how much cash does 4014.SR have

Source: FMP /balance-sheet-statement · US GAAP · Scientific and Medical Equipment House Company · Scientific and Medical Equipment House Company SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025